Pressure BioSciences, Inc. (PBIO)
USD 0.0
(-66.17%)
USD 0.0
(-66.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.5 Million USD | -94.01% |
| 2022 | -4.89 Million USD | -17.04% |
| 2021 | -4.18 Million USD | 8.74% |
| 2020 | -4.58 Million USD | 21.01% |
| 2019 | -5.8 Million USD | -29.67% |
| 2018 | -4.47 Million USD | 3.66% |
| 2017 | -4.64 Million USD | -24.4% |
| 2016 | -3.73 Million USD | -4.78% |
| 2015 | -3.56 Million USD | -6.79% |
| 2014 | -3.33 Million USD | -0.34% |
| 2013 | -3.32 Million USD | 3.94% |
| 2012 | -3.46 Million USD | -5.27% |
| 2011 | -3.29 Million USD | 3.2% |
| 2010 | -3.39 Million USD | -6.33% |
| 2009 | -3.19 Million USD | 35.64% |
| 2008 | -4.96 Million USD | 3.51% |
| 2007 | -5.14 Million USD | -26.84% |
| 2006 | -4.05 Million USD | -67.75% |
| 2005 | -2.41 Million USD | -1.55% |
| 2004 | -2.38 Million USD | -134.96% |
| 2003 | -1.01 Million USD | 32.58% |
| 2002 | -1.5 Million USD | -206.55% |
| 2001 | -490.59 Thousand USD | 85.59% |
| 2000 | -3.4 Million USD | -278.23% |
| 1999 | -900 Thousand USD | -28.57% |
| 1998 | -700 Thousand USD | -150.0% |
| 1997 | 1.4 Million USD | 55.56% |
| 1996 | 900 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.48 Million USD | 57.48% |
| 2023 Q2 | -1.08 Million USD | 70.27% |
| 2023 Q4 | -3.49 Million USD | -104.67% |
| 2023 Q3 | -1.7 Million USD | -57.72% |
| 2023 FY | -9.5 Million USD | -94.01% |
| 2023 Q1 | -3.63 Million USD | -135.15% |
| 2022 FY | -4.89 Million USD | -17.04% |
| 2022 Q2 | -901.63 Thousand USD | 17.0% |
| 2022 Q3 | -1.36 Million USD | -51.21% |
| 2022 Q4 | -1.54 Million USD | -13.47% |
| 2022 Q1 | -1.08 Million USD | 11.04% |
| 2021 FY | -4.18 Million USD | 8.74% |
| 2021 Q3 | -1.24 Million USD | -92.25% |
| 2021 Q1 | -1.07 Million USD | -3.25% |
| 2021 Q2 | -646.33 Thousand USD | 39.88% |
| 2021 Q4 | -1.22 Million USD | 1.72% |
| 2020 FY | -4.58 Million USD | 21.01% |
| 2020 Q1 | -1.39 Million USD | 28.06% |
| 2020 Q2 | -1.33 Million USD | 4.62% |
| 2020 Q3 | -818.76 Thousand USD | 38.47% |
| 2020 Q4 | -1.04 Million USD | -27.18% |
| 2019 Q2 | -1.4 Million USD | -0.26% |
| 2019 Q3 | -1.06 Million USD | 23.67% |
| 2019 Q4 | -1.93 Million USD | -81.41% |
| 2019 FY | -5.8 Million USD | -29.67% |
| 2019 Q1 | -1.39 Million USD | 7.78% |
| 2018 FY | -4.47 Million USD | 3.66% |
| 2018 Q4 | -1.51 Million USD | -62.28% |
| 2018 Q3 | -933.39 Thousand USD | -1.36% |
| 2018 Q2 | -920.89 Thousand USD | 16.89% |
| 2018 Q1 | -1.1 Million USD | 15.95% |
| 2017 Q2 | -1.2 Million USD | -20.54% |
| 2017 Q1 | -999.1 Thousand USD | -184.87% |
| 2017 FY | -4.64 Million USD | -24.4% |
| 2017 Q4 | -1.31 Million USD | -17.16% |
| 2017 Q3 | -1.12 Million USD | 6.56% |
| 2016 Q3 | -451.8 Thousand USD | 57.4% |
| 2016 FY | -3.73 Million USD | -4.78% |
| 2016 Q4 | 1.17 Million USD | 360.55% |
| 2016 Q1 | -1.04 Million USD | -11.78% |
| 2016 Q2 | -1.06 Million USD | -1.41% |
| 2015 Q1 | -874.81 Thousand USD | 4.03% |
| 2015 Q2 | -1.06 Million USD | -21.61% |
| 2015 FY | -3.56 Million USD | -6.79% |
| 2015 Q3 | -690.72 Thousand USD | 35.08% |
| 2015 Q4 | -935.74 Thousand USD | -35.47% |
| 2014 Q2 | -846.75 Thousand USD | -8.23% |
| 2014 Q4 | -911.59 Thousand USD | -14.29% |
| 2014 FY | -3.33 Million USD | -0.34% |
| 2014 Q1 | -782.36 Thousand USD | 13.08% |
| 2014 Q3 | -797.63 Thousand USD | 5.8% |
| 2013 Q4 | -900.11 Thousand USD | -6.64% |
| 2013 Q3 | -844.03 Thousand USD | 1.63% |
| 2013 FY | -3.32 Million USD | 3.94% |
| 2013 Q2 | -858.02 Thousand USD | -18.34% |
| 2013 Q1 | -725.02 Thousand USD | 35.82% |
| 2012 Q4 | -1.12 Million USD | -64.56% |
| 2012 Q2 | -682.79 Thousand USD | 29.21% |
| 2012 Q3 | -686.52 Thousand USD | -0.55% |
| 2012 Q1 | -964.58 Thousand USD | -11.07% |
| 2012 FY | -3.46 Million USD | -5.27% |
| 2011 Q3 | -745.81 Thousand USD | 11.45% |
| 2011 FY | -3.29 Million USD | 3.2% |
| 2011 Q4 | -868.43 Thousand USD | -16.44% |
| 2011 Q2 | -842.27 Thousand USD | -1.04% |
| 2011 Q1 | -833.61 Thousand USD | 1.59% |
| 2010 Q1 | -911.43 Thousand USD | -17.28% |
| 2010 FY | -3.39 Million USD | -6.33% |
| 2010 Q4 | -847.06 Thousand USD | -0.53% |
| 2010 Q3 | -842.58 Thousand USD | -5.63% |
| 2010 Q2 | -797.66 Thousand USD | 12.48% |
| 2009 Q4 | -777.14 Thousand USD | -3.04% |
| 2009 FY | -3.19 Million USD | 35.64% |
| 2009 Q1 | -849.91 Thousand USD | 5.58% |
| 2009 Q2 | -815.33 Thousand USD | 4.07% |
| 2009 Q3 | -754.18 Thousand USD | 7.5% |
| 2008 Q3 | -1.1 Million USD | 30.21% |
| 2008 Q2 | -1.58 Million USD | -15.73% |
| 2008 FY | -4.96 Million USD | 3.51% |
| 2008 Q1 | -1.37 Million USD | -5.66% |
| 2008 Q4 | -900.1 Thousand USD | 18.74% |
| 2007 FY | -5.14 Million USD | -26.84% |
| 2007 Q4 | -1.29 Million USD | 6.03% |
| 2007 Q2 | -1.36 Million USD | -24.53% |
| 2007 Q1 | -1.09 Million USD | -2.63% |
| 2007 Q3 | -1.38 Million USD | -0.91% |
| 2006 Q4 | -1.07 Million USD | -29.06% |
| 2006 FY | -4.05 Million USD | -67.75% |
| 2006 Q2 | -1.14 Million USD | -12.76% |
| 2006 Q1 | -1.01 Million USD | -84.17% |
| 2006 Q3 | -829.83 Thousand USD | 27.42% |
| 2005 Q4 | -550.55 Thousand USD | -202.16% |
| 2005 Q2 | -889.62 Thousand USD | -106.38% |
| 2005 Q1 | -431.06 Thousand USD | 44.52% |
| 2005 FY | -2.41 Million USD | -1.55% |
| 2005 Q3 | 538.9 Thousand USD | 160.58% |
| 2004 FY | -2.38 Million USD | -134.96% |
| 2004 Q3 | -625.68 Thousand USD | -53.13% |
| 2004 Q2 | -408.6 Thousand USD | -79.52% |
| 2004 Q1 | -227.6 Thousand USD | 40.73% |
| 2004 Q4 | -776.97 Thousand USD | -24.18% |
| 2003 Q1 | -190.07 Thousand USD | -313.61% |
| 2003 FY | -1.01 Million USD | 32.58% |
| 2003 Q4 | -384.02 Thousand USD | -35.48% |
| 2003 Q3 | -283.46 Thousand USD | -81.31% |
| 2003 Q2 | -156.33 Thousand USD | 17.75% |
| 2002 Q2 | -247.48 Thousand USD | 70.37% |
| 2002 Q1 | -835.21 Thousand USD | -382.71% |
| 2002 FY | -1.5 Million USD | -206.55% |
| 2002 Q4 | 88.98 Thousand USD | 117.44% |
| 2002 Q3 | -510.18 Thousand USD | -106.15% |
| 2001 Q1 | -248.91 Thousand USD | -161.61% |
| 2001 Q4 | -173.02 Thousand USD | -9.97% |
| 2001 Q2 | 88.69 Thousand USD | 135.63% |
| 2001 Q3 | -157.33 Thousand USD | -277.39% |
| 2001 FY | -490.59 Thousand USD | 85.59% |
| 2000 FY | -3.4 Million USD | -278.23% |
| 2000 Q4 | 404.01 Thousand USD | 115.19% |
| 2000 Q3 | -2.65 Million USD | -925.94% |
| 2000 Q2 | -259.24 Thousand USD | 70.84% |
| 2000 Q1 | -889.15 Thousand USD | -789.15% |
| 1999 Q1 | -400 Thousand USD | 42.86% |
| 1999 Q2 | -300 Thousand USD | 25.0% |
| 1999 Q3 | -300 Thousand USD | 0.0% |
| 1999 FY | -900 Thousand USD | -28.57% |
| 1999 Q4 | -100 Thousand USD | 66.67% |
| 1998 Q4 | -700 Thousand USD | -120.59% |
| 1998 Q3 | 3.4 Million USD | 1600.0% |
| 1998 Q2 | 200 Thousand USD | 118.18% |
| 1998 Q1 | -1.1 Million USD | -237.5% |
| 1998 FY | -700 Thousand USD | -150.0% |
| 1997 Q2 | -100 Thousand USD | -114.29% |
| 1997 Q1 | 700 Thousand USD | 133.33% |
| 1997 FY | 1.4 Million USD | 55.56% |
| 1997 Q4 | 800 Thousand USD | 166.67% |
| 1997 Q3 | 300 Thousand USD | 400.0% |
| 1996 Q4 | 300 Thousand USD | -25.0% |
| 1996 FY | 900 Thousand USD | 0.0% |
| 1996 Q3 | 400 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -3364.712% |
| IR-Med Inc. | -4.91 Million USD | -93.512% |
| Polarean Imaging plc | -12.55 Million USD | 24.313% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 2268.825% |
| Avitar, Inc. | 2.73 Million USD | 447.75% |
| AVITA Medical, Inc. | -40.4 Million USD | 76.478% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -1251.829% |
| Össur hf. | 87.46 Million USD | 110.866% |
| Zecotek Photonics Inc. | -3.65 Million USD | -159.884% |
| QHSLab, Inc. | -240.15 Thousand USD | -3857.127% |
| Wellstar International, Inc. | -1.79 Million USD | -429.525% |
| Össur hf. | 87.46 Million USD | 110.866% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 556.673% |
| Escalon Medical Corp. | -104.47 Thousand USD | -8996.212% |
| Aurora Spine Corporation | -446.19 Thousand USD | -2029.862% |
| BrainsWay Ltd. | -4.92 Million USD | -92.883% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | -0.466% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 3518.511% |
| Vivos Inc. | -2.79 Million USD | -240.238% |
| MicroPort Scientific Corporation | -516.16 Million USD | 98.159% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -3873.541% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -436.415% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -2408.104% |
| Nanomix Corporation | -8.43 Million USD | -12.637% |
| Theraclion SA | -3.48 Million USD | -173.014% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -1244.128% |
| Positron Corporation | -1.36 Million USD | -598.391% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -360.224% |
| Lombard Medical, Inc. | -29.33 Million USD | 67.604% |
| ALR Technologies Inc. | -2.94 Million USD | -222.55% |
| Stratec SE | 25.26 Million USD | 137.61% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 23745.488% |
| Heart Tronics, Inc. | 14.46 Million USD | 165.721% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -7784.903% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 54.156% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -1659.881% |
| VMS Rehab Systems, Inc. | -68.66 USD | -13841085.552% |
| Guided Therapeutics, Inc. | -3.45 Million USD | -174.902% |
| Ingen Technologies, Inc. | -1.61 Million USD | -488.938% |
| Odyssey Group International, Inc. | 14.26 Million USD | 166.638% |
| United American Healthcare Corporation | -67 Thousand USD | -14084.116% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -2232.227% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -1397.328% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -1479.888% |
| Urologix, Inc. | -6.93 Million USD | -37.134% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -652.245% |
| Nexeon MedSystems Inc. | -6.26 Million USD | -51.69% |
| SS Innovations International, Inc. | -20.66 Million USD | 54.02% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -4027.57% |
| Smith & Nephew plc | 425 Million USD | 102.236% |
| NIOX Group Plc | 4.6 Million USD | 306.595% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 2575.993% |
| Broncus Holding Corporation | -33.22 Million USD | 71.394% |
| Brain Scientific Inc. | -9.6 Million USD | 1.093% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -15556.531% |